<DOC>
	<DOCNO>NCT02732873</DOCNO>
	<brief_summary>The REKREATE project international , multi-centre , non-randomised , prospective single-arm pivotal study . All study patient receive FibroFix™ Meniscus scaffold follow provision inform consent . A study period 1 year extend follow period 3 year plan , enable thorough complete assessment performance device implant replace remove damaged meniscal tissue human . The test article multi-centre study FibroFix™ Meniscus scaffold , develop repair defect meniscus .</brief_summary>
	<brief_title>Porous Tissue Regenerative Silk Scaffold Human Meniscal Cartilage Repair</brief_title>
	<detailed_description />
	<criteria>The subject ( guardian , appropriate ) sign date specific informed consent form ; The subject age 18 ≤55 year age ; The subject able comply protocoldefined preoperative procedure , postoperative clinical radiographic evaluation recommend rehabilitation regimen determine Investigator ; The subject diagnosis MRI arthroscopically confirm irreparable medial meniscus defect ; The meniscal defect represent 25 % meniscus amenable implantation ; The peripheral meniscal rim must present ; The subject functionally intact ACL ( Anterior Cruciate Ligament ) ; Haemoglobin &gt; 9g/dL platelet count &gt; 100,000/mm3 prior Day 1 ; No contraindication general anaesthetic ; Female subject childbearing potential : negative urine pregnancy test . Subject &gt; 55 year age ; The subject functionally deficient ACL ; The subject concomitant posterior cruciate ligament insufficiency involve knee concomitant injury interferes subject 's ability comply recommend rehabilitation programme ; The subject diagnosis Grade IV Outerbridge Scale degenerative cartilage disease involve knee joint ; Patients demonstrate active local systemic infection ; Any condition , judgment Investigator would preclude adequate evaluation FibroFix™ Meniscus scaffold clinical outcome ; The subject history confirm anaphylactoid reaction ; The subject receive local administration type corticosteroid systemic administration antineoplastic , immunostimulating , immunosuppressive agent within 180 day prior schedule surgery ; The subject evidence osteonecrosis involve knee ; The subject medical history include confirm diagnosis rheumatoid inflammatory arthritis , relapse polychondritis ; If female childbearing potential : evidence positive pregnancy test state intention become pregnant next 612 month ; Current recent ( &lt; 3 month ) participation another device drug study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>